F779-0429 Screening compound: 1-(diethylsulfamoyl)-N-{3-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}piperidine-4-carboxamide

F779-0429 Screening compound: 1-(diethylsulfamoyl)-N-{3-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}piperidine-4-carboxamide
F779-0429 Screening compound: 1-(diethylsulfamoyl)-N-{3-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}piperidine-4-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound F779-0429
1-(diethylsulfamoyl)-N-{3-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}piperidine-4-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

F779-0429

Molecular Formula

C26H35N5O3S (C26 H35 N5 O3 S)

Compound Name

1-(diethylsulfamoyl)-N-{3-[2-(5-methyl-1H-1,3-benzodiazol-2-yl)ethyl]phenyl}piperidine-4-carboxamide

IUPAC name

1-(diethylsulfamoyl)-N-{3-[2-(5-methyl-1H-13-benzodiazol-2-yl)ethyl]phenyl}piperidine-4-carboxamide

SMILES

CCN(CC)S(N(CC1)CCC1C(Nc1cc(CCc2nc(cc(C)cc3)c3[nH]2)ccc1)=O)(=O)=O

InChI

InChI=1S/C26H35N5O3S/c1-4-30(5-2)35(33,34)31-15-13-21(14-16-31)26(32)27-22-8-6-7-20(18-22)10-12-25-28-23-11-9-19(3)17-24(23)29-25/h6-9,11,17-18,21H,4-5,10,12-16H2,1-3H3,(H,27,32)(H,28,29)

InChI Key

SONJWXZVJLHTOW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14966129

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

497.66

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

10.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

3.719

Distribution Coefficient, logD

3.703

Water Solubility, LogSw

-3.81

Polar Surface Area

76.842

Acid Dissociation Constant (pKa)

13.72

Base Dissociation Constant (pKb)

5.96

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

46.20

F779-0429 in Drug Discovery

Included in Screening Libraries

CNS Targets (44014 compounds)

Macl-GPIb alpha Interaction Library (22969 compounds)

SmartTM Library (51161 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular

References: we are preparing a list of scientific research reports with F779-0429 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound F779-0429?
Check Price and Availability of F779-0429, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of F779-0429 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for F779-0429
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for F779-0429
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of F779-0429 available by request